Your browser doesn't support javascript.
loading
Randomized Controlled Trial of Home-Based Hormonal Contraceptive Dispensing for Women At Risk of Unintended Pregnancy.
Melnick, Alan L; Rdesinski, Rebecca E; Marino, Miguel; Jacob-Files, Elizabeth; Gipson, Teresa; Kuyl, Marni; Dexter, Eve; Olds, David.
Afiliação
  • Melnick AL; Department of Family Medicine, Oregon Health & Science University, Portland.
  • Rdesinski RE; Department of Family Medicine, Oregon Health & Science University, Portland.
  • Marino M; Department of Family Medicine, Oregon Health & Science University, Portland.
  • Jacob-Files E; Qualitative health research consultant, BJF Research, Seattle.
  • Gipson T; Department of Family Medicine, Oregon Health & Science University, Portland.
  • Kuyl M; Department of Health and Human Services, Hillsboro, OR.
  • Dexter E; Department of Family Medicine, Oregon Health & Science University, Portland.
  • Olds D; University of Colorado, Aurora.
Perspect Sex Reprod Health ; 48(2): 93-9, 2016 06.
Article em En | MEDLINE | ID: mdl-27196986
ABSTRACT
CONTEXT Women frequently experience barriers to obtaining effective contraceptives from clinic-based providers. Allowing nurses to dispense hormonal methods during home visits may be a way to reduce barriers and improve -effective contraceptive use.

METHODS:

Between 2009 and 2013, a sample of 337 low-income, pregnant clients of a nurse home-visit program in Washington State were randomly selected to receive either usual care or enhanced care in which nurses were permitted to provide hormonal contraceptives postpartum. Participants were surveyed at baseline and every three months postpartum for up to two years. Longitudinal Poisson mixed-effects regression analysis was used to examine group differences in gaps in effective contraceptive use, and survival analysis was used to examine time until a subsequent pregnancy.

RESULTS:

Compared with usual care participants, enhanced care participants had an average of 9.6 fewer days not covered by effective contraceptive use during the 90 days following a first birth (52.6 vs. 62.2). By six months postpartum, 50% of usual care participants and 39% of enhanced care participants were using a long-acting reversible contraceptive (LARC). In analyses excluding LARC use, enhanced care participants had an average of 14.2 fewer days not covered by effective contraceptive use 0-3 months postpartum (65.0 vs. 79.2) and 15.7 fewer uncovered days 4-6 months postpartum (39.2 vs. 54.9).

CONCLUSION:

Home dispensing of hormonal contraceptives may improve women's postpartum contraceptive use and should be explored as an intervention in communities where contraceptives are not easily accessible.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prescrições de Medicamentos / Anticoncepcionais Orais Hormonais / Gravidez não Planejada / Serviços de Planejamento Familiar Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prescrições de Medicamentos / Anticoncepcionais Orais Hormonais / Gravidez não Planejada / Serviços de Planejamento Familiar Idioma: En Ano de publicação: 2016 Tipo de documento: Article